Analogue engineering still relies heavily on manual intervention, but that is changing with the growing use of AI/ML.

User simulators serve two critical roles when integrated with interactive AI systems: they enable evaluation via repeatable, ...

As a drug moves through research and regulatory processes, any mistakes in the data will be compounded. Small gaps that a ...

The UltiSim Data Fusion Plane solves this challenge by allowing mid-market organizations to connect, transform, and access disparate and siloed data across the enterprise for AI applications -- ...

In this shifting landscape, a new generation of AI-driven quantitative trading systems is emerging—powered by multimodal ...

A new suite of tools and services address need for high-quality domain-specific datasets and human feedback pipelines ...

Drug resistance remains a central barrier to durable responses across cancer therapies, spanning targeted agents, cytotoxic chemotherapy, endocrine ...

In his keynote address, Prof. Sastry emphasized that AI is dramatically accelerating drug discovery timelines, reducing costs, and enabling precision-driven research outcomes.

Understanding how these new capabilities are emerging across nuclear can help leaders position themselves for the next phase ...

As we step into 2026, the AI and analytics story for health care and life sciences isn’t about sudden disruption – it’s about ...

A research team at Tohoku University and Future University Hakodate has demonstrated that living biological neurons can be trained to perform a supervised temporal pattern learning task previously ...